|
Re: Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 11, 2019 10:41AM
|
|
Re: Patient Years & MACE rate Question
|
|
Resverlogix Corp.
|
Jul 11, 2019 01:28PM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 01:45PM
|
|
Re: Patient Years & MACE rate Question
|
6
|
Resverlogix Corp.
|
Jul 10, 2019 10:38PM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 09:00AM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 11:35AM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 01:25PM
|
|
Re: Patient Enrollment Modeling
|
1
|
Resverlogix Corp.
|
Dec 08, 2018 10:20AM
|
|
Re: Patient Enrollment Modeling
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 08:33PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 01, 2018 09:03PM
|
|
Re: Patient Enrollment Modeling
|
4
|
Resverlogix Corp.
|
Dec 02, 2018 08:07AM
|
|
Re: Patient Enrollment Modeling
|
1
|
Resverlogix Corp.
|
Dec 02, 2018 09:32AM
|
|
Re: Patient Enrollment Modeling
|
3
|
Resverlogix Corp.
|
Dec 09, 2018 09:39AM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 01:20PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 02, 2018 05:44PM
|
|
Re: Patent Applications in U.S. and Europe
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 06:55AM
|
|
Re: Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
3
|
Resverlogix Corp.
|
Nov 04, 2019 10:22AM
|
|
Re: Paris
|
2
|
Resverlogix Corp.
|
May 21, 2017 05:54PM
|
|
Re: Pan versus Selective Inhibitors....I need analogies
|
4
|
Resverlogix Corp.
|
Nov 24, 2017 02:59PM
|
|
Re: Pan versus Selective Inhibitors....I need analogies
|
5
|
Resverlogix Corp.
|
Nov 22, 2017 01:50PM
|
